Ginkgo Bioworks Holdings, Inc. (DNA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
DNA currently has 53.4M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 23.66% over the past 2 years through share issuances. Recent corporate actions include 1 stock split (positive for accessibility) and 1 reverse split (concerning signal).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 53.4M shares outstanding |
53M | 0 |
| Nov 06, 2025 |
10-Q filing | 48.5M shares outstanding |
49M | 0 |
| Aug 07, 2025 |
S-3 filing: This S-3 filing registers an indeterminate number of shares of common stock or preferred stock for sale from time to time at indeterminate prices, with an aggregate offering price not exceeding $500,000,000, which includes $400,000,000 of unsold securities from a prior registration statement and $100,000,000 of new securities. |
46M | 0 |
| Aug 07, 2025 |
10-Q filing | 47.1M shares outstanding |
47M | 0 |
| May 06, 2025 |
10-Q filing | 46.3M shares outstanding |
46M | 0 |
| Feb 25, 2025 |
10-K filing | 45.8M shares outstanding |
46M | 0 |
| Nov 12, 2024 |
10-Q filing | 45.2M shares outstanding |
45M | 0 |
| Aug 19, 2024 |
Stock Split
8-K filing: Stock split 1-for-40 | Outstanding: 1,724,120,468 → 43,103,011 |
43M | 0 |
| Aug 08, 2024 |
10-Q filing | 1724.1M shares outstanding |
1.7B | 0 |
| May 09, 2024 |
10-Q filing | 1709.1M shares outstanding |
1.7B | 0 |
| May 09, 2024 |
S-3 filing: Ginkgo Bioworks Holdings, Inc. is offering up to 18,857,026 shares of Class A common stock by the Selling Securityholders. |
1.7B | 0 |
| Feb 29, 2024 |
10-K filing | 1650.9M shares outstanding |
1.7B | 0 |
| Nov 08, 2023 |
10-Q filing | 1619.4M shares outstanding |
1.6B | 0 |
| Aug 23, 2023 |
S-3 filing: This prospectus relates to the resale or other disposition from time to time of up to 5,283,679 shares in the aggregate of Class A common stock of Ginkgo Bioworks Holdings, Inc. by the selling securityholders named in this prospectus. |
1.6B | 5.3M |
| Aug 09, 2023 |
10-Q filing | 1601.0M shares outstanding |
1.6B | 0 |
| May 10, 2023 |
10-Q filing | 1585.3M shares outstanding |
1.6B | 0 |